Orphazyme shares drop after arimoclomol fails phase 2/3 muscle-wasting disorder study
March 29 2021 - 8:19AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Orphazyme AS (NASDAQ:ORPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Orphazyme AS (NASDAQ:ORPH)
Historical Stock Chart
From Apr 2023 to Apr 2024